OTCMKTS:GTBIF Q2 EPS Forecast Lowered by Seaport Res Ptn

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Seaport Res Ptn cut their Q2 2025 earnings estimates for Green Thumb Industries in a research report issued on Wednesday, March 5th. Seaport Res Ptn analyst S. Randhawa now forecasts that the company will post earnings of $0.02 per share for the quarter, down from their prior forecast of $0.03. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Seaport Res Ptn also issued estimates for Green Thumb Industries’ Q3 2025 earnings at $0.02 EPS, Q1 2026 earnings at $0.03 EPS, Q2 2026 earnings at $0.04 EPS, Q3 2026 earnings at $0.03 EPS and Q4 2026 earnings at $0.04 EPS.

Separately, Roth Capital upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research note on Sunday, November 10th. Two analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Strong Buy” and a consensus target price of $16.50.

Green Thumb Industries Trading Up 2.5 %

Shares of Green Thumb Industries stock opened at $7.04 on Friday. The firm has a fifty day simple moving average of $7.27 and a 200-day simple moving average of $8.85. Green Thumb Industries has a 1-year low of $6.08 and a 1-year high of $16.33. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of 29.33 and a beta of 1.30.

Green Thumb Industries (OTCMKTS:GTBIF) last posted its earnings results on Wednesday, February 26th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. The business had revenue of $294.32 million during the quarter, compared to analyst estimates of $289.66 million.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.